Receiving cancer care at Vanderbilt University Medical Center
Diagnosis of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic myeloid leukemia (CML), or multiple myeloma (MM)
Initiating an oral anticancer agent, either for the first time or a change from previous oral agent
Diagnosis of 2 chronic conditions, including at least one of the following: diabetes, hypertension, hyperlipidemia, congestive heart failure, depression/anxiety, gastroesophageal reflux disease, and/or chronic obstructive pulmonary disease
Patients taking at least two chronic medications, including at least one medication for one of the conditions listed above.
Willing and able to sign informed consent.
You may not be if
Cannot communicate in English
Concurrent diagnosis of type 1 diabetes or human immunodeficiency virus
Clareo Health | Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
